Peter Greenleaf, Aurinia CEO
Aurinia will explore possible sale, following push by shareholder
Aurinia Pharmaceuticals said it will start exploring strategic alternatives, including a potential sale. The announcement follows calls by one of its major shareholders, MKT Capital …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.